PRM — Proteome Sciences Share News
0.000.00%
- £4.62m
- £19.47m
- £3.76m
UK's Proteome Sciences H1 revenue flat, loss narrows on lower costs
Proteome Sciences - Appointment of Non-Executive Director
Proteome Sciences - Interim Results H1 2026
Proteome Sciences - Further GCLP Chemoproteomics contract secured
Brief: Proteome Sciences Secures Significant Clinical Contract For Chemoproteomics Platform
Proteome Sciences - Target engagement/chemoproteomics contract
Proteome Sciences - Directorate Changes
Proteome Sciences - Annual General Meeting Statement
Brief: Proteome Sciences Reports FY Adj EBITDA Loss £1.72 Million
Proteome Sciences - Final results for the year ended 31 December 2025
Proteome Sciences - Holding(s) in Company
Proteome Sciences - Holding(s) in Company
Proteome Sciences - Result of Oversubscribed Retail Offer
Proteome Sciences - Retail Offer to raise up to £60,000
Proteome Sciences - £840,000 Fundraise and Retail Offer
Proteome Sciences - Two Further Substantial Contracts for PRM
Brief: Proteome Sciences Secures Third Contract From US Biopharma Company
Proteome Sciences - Substantial contract for Proteome Sciences
Proteome Sciences - Interim Results